Notice of Approval for Clinical Trials_Providing professional financial news and data related to Notice of Approval for Clinical Trials, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

HENGRUI PHARMA (01276.HK): Five Innovative Drugs Obtain Clinical Trial Approvals, Targeting KRAS G12D and Other Indications

Tags：

HENGRUI PHARMA 01276.HK Notice of Approval for Clinical Trials

2026-05-09

HENGRUI PHARMA(01276.HK): HRS-3005 Tablets Granted Clinical Trial Approval for B-Cell Malignancies

Tags：

HENGRUI PHARMA 01276.HK Notice of Approval for Clinical Trials

2026-05-09

Finance
AIM VACCINE(06660.HK) closed 21.83% higher, the latest market capitalization at HKD 1.56 billion
Finance
STARPLUS LEGEND(06683.HK) closed 9.83% higher, the Hang Seng Food & Beverages Sector saw divergent trends
Finance
EASY SMART GP(02442.HK) closed 12.09% higher
Finance
YUM CHINA(09987.HK) will spend HKD 27.28 million to repurchase 71.65 thousand shares on May 7, 2026
Finance
AIA(01299.HK) will spend HKD 112.23 million to repurchase 1.29 million shares on May 8, 2026
Finance
NEW VISION CO(02632.HK) closed 10.27% higher
Finance
LC LOGISTICS(02490.HK) closed 7.58% higher, the latest market capitalization at HKD 2.85 billion
Finance
160 HEALTH(02656.HK) closed 44.26% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
Finance
DRINDA(02865.HK) closed 16% higher
Finance
YUM CHINA(09987.HK) will spend USD 10.5 million to repurchase 217.65 thousand shares on May 7, 2026

Scan QR Code

Download App